Increased mTOR activation in idiopathic multicentric Castleman disease

Idiopathic multicentric Castleman disease (iMCD) is a rare and poorly understood hematologic disorder characterized by lymphadenopathy, systemic inflammation, cytopenias, and life-threatening multiorgan dysfunction. Interleukin-6 (IL-6) inhibition effectively treats approximately one-third of patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Arenas, Daniel J., Floess, Katherine, Kobrin, Dale, Pai, Ruth-Anne Langan, Srkalovic, Maya B., Tamakloe, Mark-Avery, Rasheed, Rozena, Ziglar, Jasira, Khor, Johnson, Parente, Sophia A. T., Pierson, Sheila K., Martinez, Daniel, Wertheim, Gerald B., Kambayashi, Taku, Baur, Joseph, Teachey, David T., Fajgenbaum, David C.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7205815/
https://ncbi.nlm.nih.gov/pubmed/32206779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002792
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars